Fostering the development of AI-enhanced technologies to support healthy aging in place of choice for older adults and individuals with Alzheimer’s disease.
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
AI-Driven Earpiece Wearable to Enhance Symptom Management, Self-Care, and Caregiver Support in AD/ADRD Patients
Investigators:
Selina Zhu, Lumia Health
Paolo Bonato, MGH-Spaulding Rehabilitation Center
Neuroimmune Foundation Models for Uncovering Biomarkers in Alzheimer’s Disease and Related Dementias
Investigators:
Mariano I. Gabitto, Allen Institute
